Introduction:
Carbonic anhydrase inhibitors are important agents for lowering intraocular pressure. They work by reducing aqueous humor production in the ciliary body. They are available as topical drops for long-term management and as oral therapy for acute situations.
Uses:
• Primary open-angle glaucoma.
• Ocular hypertension.
• Acute angle-closure crisis, as adjunct therapy with oral acetazolamide.
![]() |
| Carbonic Anhydrase Inhibitors for Glaucoma, Uses and Safety Guide |
Drug Class:
Topical drugs that block carbonic anhydrase II in the ciliary epithelium.
This action lowers intraocular pressure in glaucoma and ocular hypertension.
Mechanism:
• Reduce aqueous humor production.
• Produce a steady fall in intraocular pressure.
• Support optic nerve protection when used consistently.
![]() |
| Carbonic Anhydrase Inhibitors for Glaucoma, Uses and Safety Guide |
Common Drugs:
• Dorzolamide eye drops.
• Brinzolamide eye drops.
• Acetazolamide tablets, used in acute angle-closure attacks or refractory cases.
![]() |
| Carbonic Anhydrase Inhibitors for Glaucoma, Uses and Safety Guide |
Adverse Effects:
• Ocular burning or stinging.
• Blurred vision.
• Bitter taste.
• Conjunctivitis.
• Systemic acidosis, rare, with oral acetazolamide.
Contraindications:
• Sulfonamide allergy.
• Severe renal disease.
• Hyperchloremic acidosis.
• Caution in sickle cell disease.
Drug Interactions:
• High-dose aspirin increases risk of metabolic acidosis with acetazolamide.
• Diuretics increase electrolyte imbalance.
• Topiramate increases risk of metabolic acidosis.
Clinical Tips:
• Shake brinzolamide suspension before use.
• Press the nasolacrimal duct after application to reduce systemic absorption.
• Avoid oral acetazolamide in pregnancy.
• Monitor serum electrolytes during systemic therapy.
Key Takeaway:
Carbonic anhydrase inhibitors lower intraocular pressure by reducing aqueous humor formation. They work well for long-term therapy and are essential in acute angle-closure events when used with oral acetazolamide. Proper administration and monitoring improve safety and outcomes.



0 Comments